Financial Performance Highlights - Cencora's adjusted diluted EPS increased by 163% year-over-year to $442[14] - Revenue grew by 103% year-over-year[16] - Consolidated adjusted operating income increased by 153% year-over-year[16] - U S Healthcare Solutions segment operating income increased by 228% year-over-year[16] Fiscal Year 2025 Guidance - Cencora updated its fiscal year 2025 adjusted diluted EPS guidance to a range of $1570 to $1595[14] - The company anticipates consolidated revenue growth of 8% to 10%[25] - The company projects adjusted operating income growth of 135% to 155%[25] - The company expects adjusted free cash flow to be between $20 billion and $30 billion[26] Segment Performance - U S Healthcare Solutions revenue increased by 114% to $683 billion[21] - International Healthcare Solutions revenue increased by 07% to $72 billion, or 57% on a constant currency basis[23]